The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Autocrine VEGF–VEGFR2–Neuropilin-1 signaling promotes glioma stem-like cell viability and tumor growth
Open accessAbstract
Although vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2) is traditionally regarded as an endothelial cell protein, evidence suggests that VEGFRs may be expressed by cancer cells. Glioblastoma multiforme (GBM) is a lethal cancer characterized by florid vascularization and aberrantly elevated VEGF. Antiangiogenic therapy with the humanized VEGF antibody bevacizumab reduces GBM tumor growth; however, the clinical benefits are transient and invariably followed by tumor recurrence. In this study, we show that VEGFR2 is preferentially expressed on the cell surface of the CD133+ human glioma stem-like cells (GSCs), whose viability, self-renewal, and tumorigenicity rely, at least in part, on signaling through the VEGF-VEGFR2–Neuropilin-1 (NRP1) axis. We find that the limited impact of bevacizumab-mediated VEGF blockage may reflect ongoing autocrine signaling through VEGF–VEGFR2–NRP1, which is associated with VEGFR2–NRP1 recycling and a pool of active VEGFR2 within a cytosolic compartment of a subset of human GBM cells. Whereas bevacizumab failed to inhibit prosurvival effects of VEGFR2-mediated signaling, GSC viability under unperturbed or radiation-evoked stress conditions was attenuated by direct inhibition of VEGFR2 tyrosine kinase activity and/or shRNA-mediated knockdown of VEGFR2 or NRP1. We propose that direct inhibition of VEGFR2 kinase may block the highly dynamic VEGF–VEGFR2–NRP1 pathway and inspire a GBM treatment strategy to complement the currently prevalent ligand neutralization approach.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stem cells, cancer, and cancer stem cells
Reya, T., Morrison, S. J., Clarke, M. F., & Weissman, I. L. (2001) · Nature · doi:10.1038/35102167 · Cited by 9,738
The biology of VEGF and its receptors
Ferrara, N., Gerber, H.-P., & LeCouter, J. (2003) · Nature Medicine · doi:10.1038/nm0603-669 · Cited by 9,591
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Bao, S., Wu, Q., McLendon, R. E., Hao, Y., Shi, Q., Hjelmeland, A. B., Dewhirst, M. W., Bigner, D. D., & Rich, J. N. (2006) · Nature · doi:10.1038/nature05236 · Cited by 6,379
Self-citationRab27a and Rab27b control different steps of the exosome secretion pathway
Ostrowski, M., Carmo, N. B., Krumeich, S., Fanget, I., Raposo, G., Savina, A., Moita, C. F., Schauer, K., Hume, A. N., Freitas, R. P., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2000 · Cited by 2,750
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis
Bartkova, J., Hořejší, Z., Koed, K., Krämer, A., Tort, F., Zieger, K., Guldberg, P., Sehested, M., Nesland, J. M., Lukas, C., et al. (2005) · Nature · doi:10.1038/nature03482 · Cited by 2,688
Self-citationBevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
Friedman, H. S., Prados, M. D., Wen, P. Y., Mikkelsen, T., Schiff, D., Abrey, L. E., Yung, W. K. A., Paleologos, N., Nicholas, M. K., Jensen, R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.8721 · Cited by 2,466
A Perivascular Niche for Brain Tumor Stem Cells
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., Oh, E. Y., Gaber, M. W., Finklestein, D., Allen, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.11.020 · Cited by 2,197
Cancerous stem cells can arise from pediatric brain tumors
Hemmati, H. D., Nakano, I., Lazareff, J. A., Masterman-Smith, M., Geschwind, D. H., Bronner-Fraser, M., & Kornblum, H. I. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036535100 · Cited by 1,817
A Lentiviral RNAi Library for Human and Mouse Genes Applied to an Arrayed Viral High-Content Screen
Moffat, J., Grueneberg, D. A., Yang, X., Kim, S. Y., Kloepfer, A. M., Hinkle, G., Piqani, B., Eisenhaure, T. M., Luo, B., Grenier, J. K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.01.040 · Cited by 1,798
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma
Liu, G., Yuan, X., Zeng, Z., Tunici, P., Ng, H., Abdulkadir, I. R., Lu, L., Irvin, D., Black, K. L., & Yu, J. S. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-67 · Cited by 1,790
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Lentivirus-delivered stable gene silencing by RNAi in primary cells
STEWART, S. A., DYKXHOORN, D. M., PALLISER, D., MIZUNO, H., YU, E. Y., AN, D. S., SABATINI, D. M., CHEN, I. S. Y., HAHN, W. C., SHARP, P. A., et al. (2003) · RNA · doi:10.1261/rna.2192803 · Cited by 1,582
Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme
Vredenburgh, J. J., Desjardins, A., Herndon, J. E., Marcello, J., Reardon, D. A., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.2440 · Cited by 1,394
Self-citationTumour vascularization via endothelial differentiation of glioblastoma stem-like cells
Ricci-Vitiani, L., Pallini, R., Biffoni, M., Todaro, M., Invernici, G., Cenci, T., Maira, G., Parati, E. A., Stassi, G., Larocca, L. M., et al. (2010) · Nature · doi:10.1038/nature09557 · Cited by 1,379
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells
Li, Z., Bao, S., Wu, Q., Wang, H., Eyler, C., Sathornsumetee, S., Shi, Q., Cao, Y., Lathia, J., McLendon, R. E., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.018 · Cited by 1,354
Self-citationStem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor
Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A. B., Shi, Q., McLendon, R. E., Bigner, D. D., & Rich, J. N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1010 · Cited by 1,345
Self-citationGlioblastoma stem-like cells give rise to tumour endothelium
Wang, R., Chadalavada, K., Wilshire, J., Kowalik, U., Hovinga, K. E., Geber, A., Fligelman, B., Leversha, M., Brennan, C., & Tabar, V. (2010) · Nature · doi:10.1038/nature09624 · Cited by 1,203
Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation
Winkler, F., Kozin, S. V., Tong, R. T., Chae, S.-S., Booth, M. F., Garkavtsev, I., Xu, L., Hicklin, D. J., Fukumura, D., di Tomaso, E., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.10.011 · Cited by 1,170
Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P. J., Aigner, L., Brawanski, A., Bogdahn, U., & Beier, C. P. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4180 · Cited by 1,153
Production and purification of lentiviral vectors
Tiscornia, G., Singer, O., & Verma, I. M. (2006) · Nature Protocols · doi:10.1038/nprot.2006.37 · Cited by 996
PECAM-1 (CD31) Cloning and Relation to Adhesion Molecules of the Immunoglobulin Gene Superfamily
Newman, P. J., Berndt, M. C., Gorski, J., White, G. C., Lyman, S., Paddock, C., & Muller, W. A. (1990) · Science · doi:10.1126/science.1690453 · Cited by 950
Gorski, D. H., Beckett, M. A., Jaskowiak, N. T., Calvin, D. P., Mauceri, H. J., Salloum, R. M., Seetharam, S., Koons, A., Hari, D. M., Kufe, D. W., et al. (1999) · PubMed · Cited by 947
Survival of the Fittest: Cancer Stem Cells in Therapeutic Resistance and Angiogenesis
Eyler, C. E., & Rich, J. N. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1829 · Cited by 737
Self-citationMaking a tumour's bed: glioblastoma stem cells and the vascular niche
Gilbertson, R. J., & Rich, J. N. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2246 · Cited by 715
Self-citationSSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma
Son, M. J., Woolard, K., Nam, D.-H., Lee, J., & Fine, H. A. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.03.003 · Cited by 672
Integrin Alpha 6 Regulates Glioblastoma Stem Cells
Lathia, J. D., Gallagher, J., Heddleston, J. M., Wang, J., Eyler, C. E., MacSwords, J., Wu, Q., Vasanji, A., McLendon, R. E., Hjelmeland, A. B., et al. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.02.018 · Cited by 660
Self-citationButler, J. M., Kobayashi, H., & Rafii, S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2791 · Cited by 578
CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells
Wang, J., Sakariassen, P. Ø., Tsinkalovsky, O., Immervoll, H., Bøe, S. O., Svendsen, A., Prestegarden, L., Røsland, G., Thorsen, F., Stuhr, L., et al. (2008) · International Journal of Cancer · doi:10.1002/ijc.23130 · Cited by 567
Blocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.018 · Cited by 532
Lampugnani, M. G., Orsenigo, F., Gagliani, M. C., Tacchetti, C., & Dejana, E. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200602080 · Cited by 525
Transdifferentiation of glioblastoma cells into vascular endothelial cells
Soda, Y., Marumoto, T., Friedmann-Morvinski, D., Soda, M., Liu, F., Michiue, H., Pastorino, S., Yang, M., Hoffman, R. M., Kesari, S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016030108 · Cited by 515
Cancer Stem Cells in Radiation Resistance
Rich, J. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0895 · Cited by 496
Self-citationLai, A., Tran, A., Nghiemphu, P. L., Pope, W. B., Solis, O. E., Selch, M., Filka, E., Yong, W. H., Mischel, P. S., Liau, L. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.2729 · Cited by 458
Soker, S., Miao, H., Nomi, M., Takashima, S., & Klagsbrun, M. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10140 · Cited by 456
IDENTIFICATION OF A2B5+CD133− TUMOR-INITIATING CELLS IN ADULT HUMAN GLIOMAS
Ogden, A. T., Waziri, A. E., Lochhead, R. A., Fusco, D., Lopez, K., Ellis, J. A., Kang, J., Assanah, M., McKhann, G. M., Sisti, M. B., et al. (2008) · Neurosurgery · doi:10.1227/01.neu.0000316019.28421.95 · Cited by 408
Folkins, C., Man, S., Xu, P., Shaked, Y., Hicklin, D. J., & Kerbel, R. S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-4238 · Cited by 385
Folkins, C., Shaked, Y., Man, S., Tang, T., Lee, C. R., Zhu, Z., Hoffman, R. M., & Kerbel, R. S. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-0167 · Cited by 374
Roberts, M., Barry, S., Woods, A., van der Sluijs, P., & Norman, J. (2001) · Current Biology · doi:10.1016/s0960-9822(01)00442-0 · Cited by 348
Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas
Joo, K. M., Kim, S. Y., Jin, X., Song, S. Y., Kong, D.-S., Lee, J.-I., Jeon, J. W., Kim, M. H., Kang, B. G., Jung, Y., et al. (2008) · Laboratory Investigation · doi:10.1038/labinvest.2008.57 · Cited by 337
Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma
Iwamoto, F. M., Abrey, L. E., Beal, K., Gutin, P. H., Rosenblum, M. K., Reuter, V. E., DeAngelis, L. M., & Lassman, A. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bc0184 · Cited by 305
CD133 as a Marker for Cancer Stem Cells: Progresses and Concerns
Wu, Y., & Wu, P. Y. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0338 · Cited by 293
New roles for VEGF in nervous tissue?beyond blood vessels
ROSENSTEIN, J. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.022 · Cited by 282
Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis
Shibuya, M. (2008) · BMB Reports · doi:10.5483/bmbrep.2008.41.4.278 · Cited by 277
Antiangiogenic therapies for high-grade glioma
Norden, A. D., Drappatz, J., & Wen, P. Y. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.159 · Cited by 245
Brain Cancer Stem Cells Display Preferential Sensitivity to Akt Inhibition
Eyler, C. E., Foo, W.-C., LaFiura, K. M., McLendon, R. E., Hjelmeland, A. B., & Rich, J. N. (2008) · Stem Cells · doi:10.1634/stemcells.2007-1073 · Cited by 242
Self-citationAngiogenesis-independent tumor growth mediated by stem-like cancer cells
Sakariassen, P. Ø., Prestegarden, L., Wang, J., Skaftnesmo, K.-O., Mahesparan, R., Molthoff, C., Sminia, P., Sundlisæter, E., Misra, A., Tysnes, B. B., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607668103 · Cited by 211
Neuropilin-1 promotes VEGFR-2 trafficking through Rab11 vesicles thereby specifying signal output
Ballmer-Hofer, K., Andersson, A. E., Ratcliffe, L. E., & Berger, P. (2011) · Blood · doi:10.1182/blood-2011-01-328773 · Cited by 202
Jarvis, A., Allerston, C. K., Jia, H., Herzog, B., Garza-Garcia, A., Winfield, N., Ellard, K., Aqil, R., Lynch, R., Chapman, C., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm901755g · Cited by 200
Gururangan, S., Chi, S. N., Young Poussaint, T., Onar-Thomas, A., Gilbertson, R. J., Vajapeyam, S., Friedman, H. S., Packer, R. J., Rood, B. N., Boyett, J. M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.8789 · Cited by 194
Hu, B., Guo, P., Bar-Joseph, I., Imanishi, Y., Jarzynka, M. J., Bogler, O., Mikkelsen, T., Hirose, T., Nishikawa, R., & Cheng, S. Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210348 · Cited by 191
Kremer, C., Breier, G., Risau, W., & Plate, K. H. (1997) · PubMed · Cited by 189
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme
Verhoeff, J. J., van Tellingen, O., Claes, A., Stalpers, L. J., van Linde, M. E., Richel, D. J., Leenders, W. P., & van Furth, W. R. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-444 · Cited by 189
VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment
Gampel, A., Moss, L., Jones, M. C., Brunton, V., Norman, J. C., & Mellor, H. (2006) · Blood · doi:10.1182/blood-2005-12-007484 · Cited by 181
Bevacizumab Plus Irinotecan in Recurrent WHO Grade 3 Malignant Gliomas
Desjardins, A., Reardon, D. A., Herndon, J. E., Marcello, J., Quinn, J. A., Rich, J. N., Sathornsumetee, S., Gururangan, S., Sampson, J., Bailey, L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0260 · Cited by 173
Self-citationHess, C. F., Vuong, V., Hegyi, I., Riesterer, O., Wood, J. M., Fabbro, D., Glanzmann, C., Bodis, S. B., & Pruschy, M. N. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2166 · Cited by 171
Niitani, H. (1995) · PubMed · Cited by 167
Regulation of neural progenitor proliferation and survival by β1 integrins
Leone, D. P., Relvas, J. B., Campos, L. S., Hemmi, S., Brakebusch, C., Fässler, R., ffrench-Constant, C., & Suter, U. (2005) · Journal of Cell Science · doi:10.1242/jcs.02396 · Cited by 163
Norden, A. D., & Wen, P. Y. (2006) · The Neurologist · doi:10.1097/01.nrl.0000250928.26044.47 · Cited by 159
Hamerlik, P., Ehrmann, J., Hlobílková, A., Štibrániová, I., Kalita, O., Kolář, Z., & Bartek, J. J. (2008) · Cell Cycle · doi:10.4161/cc.7.16.6442 · Cited by 151
Self-citationFarnesyltransferase inhibitors disrupt EGF receptor traffic through modulation of the RhoB GTPase
Wherlock, M. D., Gampel, A., Futter, C. E., & Mellor, H. (2004) · Journal of Cell Science · doi:10.1242/jcs.01193 · Cited by 125
Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways
Li, Z., Wang, H., Eyler, C. E., Hjelmeland, A. B., & Rich, J. N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r900013200 · Cited by 118
Self-citation[22] Analysis of gene expression
Burgess, J. K., & McParland, B. E. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)56939-1 · Cited by 102
Xiao, Z., Kong, Y., Yang, S., Li, M., Wen, J., & Li, L. (2007) · Cell Research · doi:10.1038/sj.cr.7310126 · Cited by 100
Precancerous Stem Cells Can Serve As Tumor Vasculogenic Progenitors
Shen, R. Z., Ye, Y., Chen, L., Yan, Q., Barsky, S. H., & Gao, J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001652 · Cited by 100
Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.
Ishida, S., Shinoda, K., Kawashima, S., Oguchi, Y., Okada, Y., & Ikeda, E. (2000) · PubMed · Cited by 96
Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma
Verhoeff, J. J. C., Lavini, C., Linde, M. E. V., Stalpers, L. J. A., Majoie, C. B. L. M., Reijneveld, J. C., van Furth, W. R., & Richel, D. J. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp591 · Cited by 94
Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR
Graeven, U., Fiedler, W., Karpinski, S., Ergün, S., Kilic, N., Rodeck, U., Schmiegel, W., & HOSSFELD, D. K. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050325 · Cited by 91
Targeting Neuropilin-1 to Inhibit VEGF Signaling in Cancer: Comparison of Therapeutic Approaches
Gabhann, F. M., & Popel, A. S. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0020180 · Cited by 80
The VEGFR2 receptor tyrosine kinase undergoes constitutive endosome-to-plasma membrane recycling
Jopling, H. M., Howell, G. J., Gamper, N. L., & Ponnambalam, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.04.093 · Cited by 66
Hlobílková, A., Ehrmann, J., Hamerlik, P., KREJCI, V., Kalita, O., & Kolář, Z. (2009) · Neoplasma · doi:10.4149/neo_2009_04_284 · Cited by 56
Self-citationCD133+ niches and single cells in glioblastoma have different phenotypes
Christensen, K. G., Schrøder, H. D., & Kristensen, B. W. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0488-y · Cited by 54
Tokuyama, W., Mikami, T., Masuzawa, M., & Okayasu, I. (2009) · Human Pathology · doi:10.1016/j.humpath.2009.08.021 · Cited by 54
Bevacizumab for Malignant Gliomas
IWAMOTO, F. M., & Fine, H. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.11 · Cited by 49
Combining radiotherapy and angiogenesis inhibitors: Clinical trial design
Citrin, D. E., Ménard, C. M., & Camphausen, K. A. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.065 · Cited by 34
Meißner, M., Reichenbach, G., Stein, M., Hrgović, I., Kaufmann, R., & Gille, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3150 · Cited by 26
Shintani, S., Li, C., Mihara, M., Klosek, S. K., Terakado, N., Hino, S., & Hamakawa, H. (2005) · Oral Oncology · doi:10.1016/j.oraloncology.2005.06.010 · Cited by 12
(2003) · PubMed
Cited by
Goel, H. L., & Mercurio, A. M. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3627 · Cited by 1,253
Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Phi, L. T. H., Sari, I. N., Yang, Y.-G., Lee, S.-H., Jun, N., Kim, K. S., Lee, Y. K., & Kwon, H. Y. (2018) · Stem Cells International · doi:10.1155/2018/5416923 · Cited by 994
Cooper, J., & Giancotti, F. G. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.01.007 · Cited by 945
Unravelling cancer stem cell potential
Beck, B., & Blanpain, C. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3597 · Cited by 905
Cancer Stem Cells: Basic Concepts and Therapeutic Implications
Nassar, D., & Blanpain, C. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044438 · Cited by 869
Metadata
- Authors
- Hamerlik, P., Lathia, J. D., Rasmussen, R., Wu, Q., Bartkova, J., Lee, M., Moudry, P., Bartek, J., Fischer, W., Lukas, J., Rich, J. N., & Bartek, J.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-03-05
- Volume
- 209
- Issue
- 3
- Pages
- 507-520
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2166637572
- Cited by
- 406
- References
- 77
- FWCI
- 13.01
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.